Global antiviral R&D is slowing when the world can least afford it, new analysis shows CAMBRIDGE, Mass., May 5, 2025 /PRNewswire/ — The INTREPID Alliance today released the fourth edition of its Antiviral Clinical and Preclinical Development Landscape, a comprehensive analysis of the…
